AI assistant
Sending…
ProPhase Labs, Inc. — Director's Dealing 2017
Oct 5, 2017
34999_dirs_2017-10-05_1c7922fa-a740-4836-9ab8-6d2d7a5475a5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: ProPhase Labs, Inc. (PRPH)
CIK: 0000868278
Period of Report: 2017-10-02
Reporting Person: Brady Monica L. (Chief Accounting Officer)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock, par value $0.0005 | 7400 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Option (right to buy) | $2.15 | 2024-09-26 | Common Stock (25000) | Direct |
Footnotes
F1: 25% of these shares were vested and exercisable as of September 26, 2017, the date of grant, and the remaining 75% of the shares will vest in three annual installments beginning on September 26, 2018.
More from ProPhase Labs, Inc.
Regulatory Filings
2026
Mar 27
Regulatory Filings
2026
Feb 13
Regulatory Filings
2026
Feb 13
Regulatory Filings
2026
Jan 27
Regulatory Filings
2026
Jan 23
Delisting Announcement
2026
Jan 23
Regulatory Filings
2026
Jan 23
Regulatory Filings
2026
Jan 9
Regulatory Filings
2026
Jan 9
Regulatory Filings
2026
Jan 2